MedVentive Recognized for Industry Best Practice in the Management of Pharmacy Costs.

CAMBRIDGE, Mass. -- U.S. Department of Health and Human Services Study Profiles PRISM(R) Drug Substitution System and Details Cost Savings of $8 Million

In a report recently released by the U.S. Department of Health and Human Service's Office of the Assistant Secretary for Planning and Evaluation, MedVentive, a provider of medical cost containment and healthcare quality improvement solutions, was identified as a Best Practice vendor of pharmacy cost management products and services. In addition to slowing dramatically the rate of pharmaceutical cost inflation in the member population profiled in the report, MedVentive delivered more than $8 million in direct cost savings through the deployment of PRISM(R), the company's proprietary Web-based drug substitution system.

The report, authored by Abt Associates, a leading government and business research and consulting firm, highlighted PRISM(R) as the core of an integrated Pharmacy Risk Management Program at the Provider Service Network, a risk-bearing provider group based in Boston. The program uses technology from MedVentive to deliver detailed formulary information, customized utilization and cost reports, and automated therapeutic interchange data directly into the hands of physician decision-makers.

"This study validates and quantifies the results MedVentive has been able to deliver for its clients. Our approach provides a clear blueprint for other organizations looking to manage their pharmacy costs more effectively through a combination of technology, information-sharing and physician education," noted Jonathan M. Niloff, M.D., President and CEO of MedVentive. "As pharmacy costs continue to grow at more than twice the rate of overall health costs, innovative solutions like PRISM(R) are more critical than ever."

PRISM(R) is a complete, end-to-end pharmacy cost management solution in use by leading IPAs, group practices and integrated delivery systems. By seamlessly combining customized formulary information with actual pharmacy claims experience, MedVentive's web-based PRISM(R) delivers specific therapeutic interchange recommendations directly to physicians.

The full report, Identification and Description of Industry Best Practices to Manage the Costs of Prescription Drugs, can be downloaded from the website of the Department of Health and Human Service's Assistant Secretary for Planning and Evaluation at: http://aspe.hhs.gov/sp/cost/, or at www.MedVentive.com. The Provider Service Network Case Study, highlighting MedVentive's role in pharmacy cost containment, begins on page 17 of the report.

About MedVentive

For nearly ten years, MedVentive has worked with leading academic hospitals, health plans and physicians to develop and deploy innovative, clinically sophisticated approaches to successfully reduce healthcare costs and improve quality. Healthcare providers, payor organizations and self-insured employers use MedVentive's technology and services to identify their greatest healthcare improvement opportunities and act quickly and efficiently to effect change through customized interventions. For more information, visit www.MedVentive.com.